The Source Blog
Recent Action in Pharmaceuticals
Introduced: 2024 Status: Enacted
This bill relates to pharmacy benefits and regulations for Pharmacy Benefit Managers (PBMs) in Oregon. The act requires PBMs to be licensed and alters the definition of a PBM. It modifies the way PBMs can …
HB 4028 – Oregon
Introduced: 2024 Status:
This bill is related to health care and specifically addresses the issue of drug accessibility in Oregon. The bill has two major components. Firstly, the bill restricts the actions of drug manufacturers by preventing them …
SB 228 – Florida
Introduced: 2024 Status:
Health Insurance Cost Sharing: Defining the term “cost-sharing requirement”; requiring specified individual health insurers and their pharmacy benefit managers to apply payments by or on behalf of insureds toward the total contributions of the insureds’ …
HB 363 – Florida
Introduced: 2024 Status:
Health Insurance Cost Sharing: Requires specified individual health insurers, group insurers, HMOs & their pharmacy benefit managers to apply payments of prescription drugs by or on behalf of insureds & subscribers toward total contributions of …
SB 1608 – Florida
Introduced: 2024 Status:
Prohibiting certain actions by health insurance issuers, pharmacy benefit managers, or other third-party payors, or their agents, relating to reimbursement to a 340B entity for 340B drugs; prohibiting certain actions by manufacturers relating to interference …
SB 100 – Wyoming
Introduced: 2024 Status: Enacted
AN ACT relating to the insurance code; providing regulations for payment of claims from insurers or the insurer’s intermediary to pharmacies; providing definitions; requiring rulemaking; providing applicability; and providing for effective dates.
HB 165 – New Mexico
Introduced: 2024 Status: Enacted
An act relating to pharmaceutical drugs; requiring Medicaid managed care organizations to reimburse community-based pharmacy providers for the full cost of prescription drugs plus a professional dispensing fee; requiring the health care authority department to …
Next | See all Legislation Records
District Court: Eastern District of Pennsylvania Status: Decided
FTC alleged AbbVie sued generic companies for patent infringement over their proposed generic version of the testosterone gel, AndroGel, without justifiable grounds but merely to …
In the Matter of Impax Laboratories Inc. – Federal
District Court: Federal Trade Commission Status: Pending
The Federal Trade Commission sued generic drugmaker Impax Laboratories Inc. for allegedly accepting more than $100 million to delay its release of a generic version …
In re: EPIPEN (Epinephrine Injection, USP) Marketing, Sales Practices, and Antitrust Litigtion – Illinois, Kansas, New Jersey, Washington
District Court: District of Kansas Status: Pending
The plaintiffs in the case allege Mylan N.V. created and exploited an EpiPen monopoly by providing aggressive rebates and incentives to pharmacy benefit managers to …
Sentry Data Sys. v. CVS Health – Florida
District Court: S.D. Florida Status: Pending
340B administrator Sentry Data Systems sued CVS pharmacy alleging that since CVS aquired Wellpartner, the company has engaged in unlawful tying, using its status as …
Previous | See all Litigation Records
News & Opinions
Rebecca PiferApril 19, 2024
Alexa CoultoffMarch 21, 2024
Michael McAuliffMarch 19, 2024
Bob HermanMarch 18, 2024
Articles & Reports
Health Affairs Forefront November 28, 2023
Health Affairs Forefront November 16, 2023
Health Affairs November 6, 2023
Trends in Pharmaceuticals
State Pharmaceutical Legislation
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2019 session. Click to see 2018 trends for a side-by-side comparison.
2019 Drug Pricing Transparency Legislation
Pharmaceutical price transparency legislation requires disclosures from drug manufacturers and insurers to help lawmakers and the public better understand how drugs are priced and how those prices affect insurance premiums. Click to see 2018 trends for a side-by-side comparison.
-
Key:
- Enacted
- Considered
2019 Pharmaceutical Rate-Setting Legislation
Rate setting legislation either establishes the price of a prescription drug or sets the maximum amount a payer can pay for a drug. Click on highlighted states to see rate-setting legislation considered or enacted in the 2019 session. Click to see 2018 trends for a side-by-side comparison.
-
Key:
- Enacted
- Considered
2019 Drug Importation Legislation
Click on highlighted states to see drug importation legislation considered or enacted in the 2019 session. Click to see 2018 trends for a side-by-side comparison.
-
Key:
- Enacted
- Considered
2019 Drug Price Gouging Prohibition Legislation
Price gouging prohibitions typically empower the state Attorney General to act if the price of a drug is raised above a threshold. Click on highlighted states to see legislation considered in the 2019 session. Click to see 2018 trends for a side-by-side comparison.
-
Key:
- Enacted
- Considered
2019 Pharmacy Benefit Manager Regulation Legislation
Legislation to regulate Pharmacy Benefit Managers (PBMs) typically include provisions that 1) require PBMs to register with the state, 2) mandate disclosures by PBMs, or 3) prevent PBMs from incentivizing the use of mail-order pharmacies. Click to see 2018 trends for a side-by-side comparison.
-
Key:
- Enacted
- Considered